| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
27,465 |
25,066 |
$1.66M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
10,756 |
10,707 |
$845K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
11,449 |
10,688 |
$805K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
6,088 |
6,066 |
$475K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
18,751 |
18,648 |
$456K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,506 |
3,414 |
$333K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,116 |
3,104 |
$269K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
20,737 |
18,420 |
$194K |
| 99460 |
|
3,422 |
3,390 |
$186K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
3,370 |
3,314 |
$141K |
| 54150 |
|
1,679 |
1,657 |
$94K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,362 |
1,317 |
$45K |
| 92587 |
|
3,448 |
3,429 |
$43K |
| 99215 |
Prolong outpt/office vis |
292 |
284 |
$41K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,561 |
1,534 |
$40K |
| 92015 |
Determination of refractive state |
3,236 |
3,228 |
$37K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
512 |
501 |
$34K |
| 83655 |
|
3,250 |
3,237 |
$33K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,572 |
2,554 |
$25K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
562 |
554 |
$24K |
| 99381 |
|
281 |
280 |
$24K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,201 |
1,180 |
$15K |
| 99462 |
|
628 |
521 |
$15K |
| 96127 |
|
3,893 |
3,657 |
$11K |
| 98966 |
|
3,133 |
2,346 |
$9K |
| 99383 |
|
79 |
77 |
$7K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
170 |
169 |
$6K |
| 36416 |
|
3,959 |
3,941 |
$6K |
| 80061 |
Lipid panel |
530 |
528 |
$6K |
| 85018 |
|
2,611 |
2,600 |
$5K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
227 |
226 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
288 |
264 |
$3K |
| G9002 |
Coordinated care fee, maintenance rate |
390 |
381 |
$2K |
| 99382 |
|
24 |
24 |
$2K |
| 81002 |
|
752 |
737 |
$2K |
| 87634 |
|
42 |
42 |
$2K |
| 90677 |
|
953 |
952 |
$1K |
| 90671 |
|
273 |
272 |
$981.60 |
| 96380 |
|
46 |
46 |
$921.17 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
79 |
74 |
$699.24 |
| 90651 |
|
1,424 |
1,418 |
$656.50 |
| 90620 |
|
291 |
291 |
$360.40 |
| 90686 |
|
5,648 |
5,603 |
$219.61 |
| 99051 |
|
81 |
77 |
$190.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
127 |
120 |
$103.47 |
| 90619 |
|
751 |
749 |
$82.15 |
| 90656 |
|
416 |
416 |
$22.35 |
| 90744 |
|
3,967 |
3,949 |
$1.00 |
| 90633 |
|
4,231 |
4,209 |
$0.00 |
| 90670 |
|
6,716 |
6,673 |
$0.00 |
| 90710 |
|
1,448 |
1,440 |
$0.00 |
| 90461 |
|
11,744 |
11,687 |
$0.00 |
| 90707 |
|
1,959 |
1,948 |
$0.00 |
| 90734 |
|
607 |
601 |
$0.00 |
| 90715 |
|
671 |
667 |
$0.00 |
| 90685 |
|
100 |
99 |
$0.00 |
| 90696 |
|
1,341 |
1,335 |
$0.00 |
| 90680 |
|
5,498 |
5,466 |
$0.00 |
| 90698 |
|
7,592 |
7,553 |
$0.00 |
| 90716 |
|
1,950 |
1,939 |
$0.00 |
| 94760 |
|
646 |
596 |
$0.00 |
| 90697 |
|
171 |
171 |
$0.00 |
| 90381 |
|
69 |
67 |
$0.00 |